Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 18, 2025 13:00 ET | Source: DelveInsight Business Research LLP

Chronic Venous Insufficiency Market to Increase at a CAGR of 9.4% During the Forecast Period (2025–2034) Due to the Launch of Emerging Therapies and Chronic Venous Insufficiency Medical Devices | DelveInsight

New York, USA, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Chronic Venous Insufficiency Market to Increase at a CAGR of 9.4% During the Forecast Period (2025–2034) Due to the Launch of Emerging Therapies and...
August 19, 2025 06:30 ET | Source: Merakris Therapeutics

Merakris Therapeutics Receives USPTO Notice of Allowance for Foundational Patent Supporting MTX-001 Biologic Drug Platform

RESEARCH TRIANGLE PARK, N.C., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Merakris Therapeutics today announced the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S....
February 20, 2024 06:15 ET | Source: Merakris Therapeutics

Merakris Therapeutics to Release Final Part 1 Data From Phase 2 Multicenter Investigational Drug Study for Dermacyte® Liquid

Merakris to present encouraging Phase 2 clinical drug trial data at annual Treasure Hunt Podiatry and Wound Conference in Los Angeles, CA, February 24-25.
December 05, 2023 06:30 ET | Source: Merakris Therapeutics

Merakris To Share Data from Fully Enrolled First Part of Two-Part Dermacyte® Liquid Clinical Trial

Merakris Therapeutics announces it has fully enrolled the first part of a clinical trial to evaluate its investigational drug product, Dermacyte® Liquid.
November 02, 2021 20:00 ET | Source: DelveInsight Business Research LLP

Chronic Venous Insufficiency Pipeline: Therapeutic Assessment, Emerging Drugs, Novel Devices, Key Pharma Players, Clinical Trials, and Growth Prospects Analysis | DelveInsight

Las Vegas, USA, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Chronic Venous Insufficiency Pipeline: Therapeutic Assessment, Emerging Drugs, Novel Devices, Key Pharma Players, Clinical Trials, and Growth...